Piper Jaffray Lowers PT on Allergan to $87

Symbols: AGN
Share

Piper Jaffray has lowered the price target on Allergan (NYSE: AGN) from $89 to $87 and maintains its Neutral rating.


 
 
< Previous
Deutsche Bank Raises PT on Norfolk Southern to $76
Next >
Morgan Stanley Lowers PT on Shutterfly to $65
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust